These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 3119728
1. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months]. Gilloz A, Sauvage I, Gremillet E, Héritier P, Richard A, el Hajj E, Diez-Yanguas J. J Urol (Paris); 1987; 93(4):197-202. PubMed ID: 3119728 [Abstract] [Full Text] [Related]
2. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation]. Wang SH. Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342 [Abstract] [Full Text] [Related]
3. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R. Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [Abstract] [Full Text] [Related]
4. [Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?]. Egghart G, Steegmüller O, Wenderoth U, Hautmann R. Urologe A; 1988 May; 27(3):147-51. PubMed ID: 3136576 [Abstract] [Full Text] [Related]
5. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG]. Wetzel O, Glemain P, Bouchot O, Guillonneau B, Baron M, Buzelin JM, Auvigne J. Prog Urol; 1993 May; 3(4):595-607. PubMed ID: 8401620 [Abstract] [Full Text] [Related]
14. [Prevention of postoperative recurrence of bladder cancer: a clinical study]. Yang D, Li S, Wang H, Li X, Liu S, Han W, Hao J, Zhang H. Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):464-5. PubMed ID: 11829890 [Abstract] [Full Text] [Related]
15. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT, Yildirim U, Zorlu F, Ozen H. J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [Abstract] [Full Text] [Related]
16. Prophylactic instillation therapy of superficial bladder cancer. A randomized study comparing mitomycin C and adriamycin with special reference to DNA ploidy. Gustafson H, Wijkström H, Nyman C, Brolin J, Borgström E, Tribukait B. Scand J Urol Nephrol Suppl; 1991 May; 138():187-91. PubMed ID: 1785002 [Abstract] [Full Text] [Related]
17. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S. J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865 [Abstract] [Full Text] [Related]
18. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T, Tozawa K, Yamada Y, Sakagami H, Ueda K, Kohri K. J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375 [Abstract] [Full Text] [Related]
19. [Our experience with mitomycin C in the prophylaxis of superficial bladder tumors; retrospective study]. Moyano Calvo JL, Herrero Torres L, Melón Rey FJ, Rabadán Ruiz M, Pereira Sanz I. Arch Esp Urol; 1994 Oct; 47(8):750-4. PubMed ID: 7818293 [Abstract] [Full Text] [Related]
20. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J, Caldarera E, Pavone-Macaluso M. J Clin Oncol; 2003 Dec 01; 21(23):4270-6. PubMed ID: 14581436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]